CRIS Current Research Information System

OCADLIKOVA, DARINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.237
AS - Asia 1.733
EU - Europa 1.448
AF - Africa 107
SA - Sud America 88
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 2
Totale 5.621
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.200
SG - Singapore 508
VN - Vietnam 460
CN - Cina 375
GB - Regno Unito 355
SE - Svezia 261
IT - Italia 206
DE - Germania 159
IN - India 107
HK - Hong Kong 90
FR - Francia 81
BR - Brasile 62
RU - Federazione Russa 61
IE - Irlanda 56
NL - Olanda 56
UA - Ucraina 44
FI - Finlandia 39
ZA - Sudafrica 36
KR - Corea 33
BG - Bulgaria 32
JP - Giappone 28
JO - Giordania 25
CA - Canada 24
CI - Costa d'Avorio 23
BE - Belgio 21
EE - Estonia 20
TG - Togo 17
TH - Thailandia 16
AR - Argentina 13
BD - Bangladesh 13
ID - Indonesia 13
PH - Filippine 12
TR - Turchia 11
SC - Seychelles 10
CH - Svizzera 9
AT - Austria 8
MX - Messico 8
PL - Polonia 8
ES - Italia 7
EG - Egitto 6
LB - Libano 6
PK - Pakistan 6
RO - Romania 6
IQ - Iraq 5
NG - Nigeria 5
CL - Cile 4
CZ - Repubblica Ceca 4
AU - Australia 3
IR - Iran 3
KZ - Kazakistan 3
LT - Lituania 3
MY - Malesia 3
NZ - Nuova Zelanda 3
OM - Oman 3
PE - Perù 3
SA - Arabia Saudita 3
SN - Senegal 3
CO - Colombia 2
ET - Etiopia 2
GR - Grecia 2
JM - Giamaica 2
KG - Kirghizistan 2
NO - Norvegia 2
PT - Portogallo 2
SK - Slovacchia (Repubblica Slovacca) 2
TN - Tunisia 2
UZ - Uzbekistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AM - Armenia 1
BF - Burkina Faso 1
DO - Repubblica Dominicana 1
EC - Ecuador 1
EU - Europa 1
HN - Honduras 1
HU - Ungheria 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LI - Liechtenstein 1
LV - Lettonia 1
MA - Marocco 1
MU - Mauritius 1
NP - Nepal 1
QA - Qatar 1
SI - Slovenia 1
SR - Suriname 1
SV - El Salvador 1
UY - Uruguay 1
VE - Venezuela 1
Totale 5.621
Salva come PNG Salva come JPEG
Città #
Singapore 363
Southend 322
Ashburn 235
Fairfield 222
Chandler 210
San Jose 114
Ho Chi Minh City 112
Wilmington 93
Ann Arbor 91
Hanoi 88
Santa Clara 87
Woodbridge 85
Hong Kong 82
Houston 81
Seattle 77
Princeton 72
Cambridge 60
Dublin 55
Bologna 50
Beijing 44
Hefei 40
Boardman 39
Helsinki 33
Lauterbourg 32
New York 32
Sofia 32
Nanjing 27
Tokyo 27
Westminster 27
Amman 25
Seoul 24
Abidjan 23
Dong Ket 23
Los Angeles 23
Padova 23
Brussels 21
Jacksonville 20
Buffalo 17
Council Bluffs 17
Jinan 17
Lomé 17
Berlin 16
Frankfurt am Main 16
Hyderabad 16
Redwood City 15
San Diego 15
Da Nang 14
Pune 14
Haiphong 13
Milan 12
Redondo Beach 12
Shenyang 12
Toronto 12
Dallas 11
Jakarta 11
Hebei 10
Nuremberg 10
São Paulo 10
Bangkok 9
Bremen 9
Chicago 9
Guangzhou 9
London 9
Benevento 8
Bern 8
Changsha 8
Johannesburg 8
San Francisco 8
Tianjin 8
Yubileyny 8
Amsterdam 7
Atlanta 7
Orem 7
Redmond 7
Shanghai 7
Dhaka 6
Florence 6
Mülheim 6
Nanchang 6
Ninh Bình 6
Phoenix 6
Turin 6
Warsaw 6
Wuhan 6
Zhengzhou 6
Biên Hòa 5
Hamm 5
Rome 5
Shenzhen 5
Abeokuta 4
Cairo 4
Dearborn 4
Gradara 4
Hangzhou 4
Hải Dương 4
Jiaxing 4
Medford 4
Montreal 4
Munich 4
New Delhi 4
Totale 3.561
Salva come PNG Salva come JPEG
Nome #
CD103 marks a subset of human CD34+-derived langerin+ dendritic cells that induce T-regulatory cells via indoleamine 2,3-dioxygenase-1 256
ATP release from chemotherapy-treated dying leukemia cells Elicits an immune suppressive effect by increasing regulatory T cells and Tolerogenic dendritic cells 225
Indoleamine 2,3-dioxygenase-expressing leukemic dendritic cells impair a leukemia-specific immune response by inducing potent T regulatory cells. 220
Larger size of donor alloreactive NK cell repertoire correlates with better response to NK cell immunotherapy in elderly acute myeloid leukemia patients 215
Immunosenescence and immunotherapy in elderly acute myeloid leukemia patients: Time for a biology-driven approach 212
Flow cytometry analysis of T-cell subsets in cerebrospinal fluid of narcolepsy type 1 patients with long-lasting disease 209
Mesenchymal stromal cells from myelodysplastic and acute myeloid leukemia patients display in vitro reduced proliferative potential and similar capacity to support leukemia cell survival 203
Donor Natural Killer (NK) Alloreactivity Predicts Long-Term Relapse-Free Survival in Acute Myeloid Leukemia Patients Undergoing Immunotherapy with NK Cells 198
Long-Term Outcome After Adoptive Immunotherapy With Natural Killer Cells: Alloreactive NK Cell Dose Still Matters 197
The more, the better: "Do the right thing" for natural killer immunotherapy in acute myeloid leukemia 195
Chemotherapy-Induced Tumor Cell Death at the Crossroads Between Immunogenicity and Immunotolerance: Focus on Acute Myeloid Leukemia 187
The SOCS3-independent expression of IDO2 supports the homeostatic generation of T regulatory cells by human dendritic cells. 186
PGE2-induced IDO1 inhibits the capacity of fully mature DCs to elicit an in vitro antileukemic immune response 184
The role of the immunosuppressive microenvironment in acute myeloid leukemia development and treatment. 183
Extracellular ATP exerts opposite effects on activated and regulatory CD4 + T cells via purinergic P2 receptor activation 178
An IDO1-related immune gene signature predicts overall survival in acute myeloid leukemia 176
Immune characterization in Narcolepsy Type 1. 167
Ex vivo characterization of acute myeloid leukemia patients undergoing hypomethylating agents and venetoclax regimen reveals a venetoclax-specific effect on non-suppressive regulatory T cells and bona fide PD-1+TIM3+ exhausted CD8+ T cells 162
In vitro activation of cytotoxic T-lymphocytes by hTERT-pulsed dendritic cells. 157
Generation of myeloma-specific T cells using dendritic cells loaded with MUC1- and hTERT- drived nonapeptides or myeloma cell apoptotic bodies. 155
Indoleamine 2,3-Dioxygenase (IDO) Is Associated with High Incidence of Chemorefractory Disease in Acute Myeloid Leukemia (AML) Patients 150
Long-Term Outcome After Adoptive Immunotherapy With Natural Killer Cells: Alloreactive NK Cell Dose Still Matters 149
Sunitinib Exerts In Vitro Immunomodulatory Activity on Sarcomas via Dendritic Cells and Synergizes With PD-1 Blockade 142
Efficacy and safety of Id-protein-loaded dendritic cell vaccine in patients with multiple myeloma – Phase II study results 138
Individual myeloma-specific T-cell clones eliminate tumour cells and correlate with clinical outcomes in patients with multiple myeloma. 138
Flow cytometry T cell profiling in a recent-onset narcoleptic type 1 child: a case report 137
Isolation and expansion of allogeneic myeloma-specific interferon-gamma producing T cells for adoptive immunotherapy. 136
Selective depletion of alloreactive T cells and study of anti-tumor activity of specific T cell clones in patients with leukemia. 131
The preparation of anticancer vaccine for patients with multiple myeloma on the base of monoclonal immunoglobulin loaded dendritic cells. 128
Generation of dendritic cells using cell culture bags--description of a method and review of literature. 126
Dendritic cell counts and their subsets during treatment of multiple myeloma. 124
Release of IFNg by Acute Myeloid Leukemia Cells Remodels Bone Marrow Immune Microenvironment by Inducing Regulatory T Cells 121
The preparation of myeloma-specific T cells activated with dendritic cells loaded with nonapeptides derived from mucin protein MUC1 and catalytic subunit of telomerase hTERT. 108
A screening of antineoplastic drugs for acute myeloid leukemia reveals contrasting immunogenic effects of etoposide and fludarabine 92
Noncanonical NF-κB signaling in dendritic cells is required for ATP-driven indoleamine 2,3-dioxygenase 1 induction through P2Y11 receptor 39
Induction of regulatory T Cells by dendritic cells through indoleamine 2,3-dioxygenase: a potent mechanism of acquired peripheral tolerance 2
Totale 5.726
Salva come PNG Salva come JPEG
Categoria #
all - tutte 14.802
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.802
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021152 0 0 0 0 0 0 0 0 0 21 13 118
2021/2022620 28 26 43 33 71 35 10 56 28 42 141 107
2022/2023847 120 132 51 103 46 73 36 57 134 12 52 31
2023/2024244 20 36 9 34 21 73 13 4 9 5 17 3
2024/2025749 40 124 43 56 118 48 40 28 15 67 41 129
2025/20261.806 124 142 132 166 199 122 203 108 446 164 0 0
Totale 5.726